Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382
- 1 December 1988
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 27 (26), 9160-9165
- https://doi.org/10.1021/bi00426a013
Abstract
A congenitally dysfunctional form of prothrombin, prothrombin Quick, was isolated from the plasma of an individual with less than 2% of normal prothrombin activity. Following activation of prothrombin Quick, two dysfunctional thrombins, thrombin Quick I and thrombin Quick II, were isolated. Functional characterization of thrombin Quick I indicated an increase in KM and a decrease in kcat, relative to thrombin, for release of fibrinopeptide A. Comparison of kcat/KM for thrombin Quick I to the value obtained for thrombin yielded a relative catalytic efficiency of 0.012 for thrombin Quick I [Henriksen, R. A., and Owen, W. G. (1987) J. Biol. Chem. 262, 4664-4669]/ Lysyl endopeptidase digestion of reduced and S-carboxymethylated thrombin and thrombin Quick I has resulted in the identification of an altered peptide in this dysthrombin. Edman degradation of the isolated peptide has shown that the altered residue in this protein is Arg-382 which is replaced by Cys. This could result from a point mutation in the Arg codon, CGC, to yield TGC. Together, these results indicate that Arg-382 is a critical residue in determining the specificity of thrombin toward fibrinogen. Similar relative activities for thrombin Quick I in stimulating platelet aggregation, in the release of prostacyclin from human umbilical vein endothelium, and in the release of fibrinopeptide A suggest that these activities of thrombin share the same specificity determinants.This publication has 24 references indexed in Scilit:
- Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin.Journal of Biological Chemistry, 1984
- Characterization of bovine prothrombin mRNA and its translation productBiochemistry, 1984
- Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.Proceedings of the National Academy of Sciences, 1984
- Restriction sites containing CpG show a higher frequency of polymorphism in human DNACell, 1984
- Evidence that activation of platelets and endothelium by thrombin involves distinct sites of interaction. Studies with the dysthrombin, Thrombin Quick I.Journal of Biological Chemistry, 1983
- Novel Structure Elucidation Strategy for Genetically Abnormal Fibrinogens with Incomplete Fibrinopeptide Release as Applied to Fibrinogen SchwarzachHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1983
- Identification of a congenital dysthrombin, thrombin Quick.Journal of Clinical Investigation, 1980
- The covalent differences between bovine alpha- and beta-thrombin. A structural explanation for the changes in catalytic activity.Journal of Biological Chemistry, 1979
- Covalent modification of human alpha-thrombin with pyridoxal 5'-phosphate. Effect of phosphopyridoxylation on the interaction of thrombin with heparin.Journal of Biological Chemistry, 1979
- Primary structure of human prethrombin 2 and alpha-thrombin.Journal of Biological Chemistry, 1977